FDA's COVID-19 vaccination strategy redesign will be discussed before it can be accepted in the United States.
(Photo : Photo by Spencer Platt/Getty Images)
A pharmacy in Grand Central Terminal advertises the COVID-19 vaccine on December 09, 2021 in New York City. As the fast-spreading new Omicron variant of COVID-19 has been detected in at least 19 states, health officials are urging Americans to get vaccinated and receive their booster shots.
The Food and Drug Administration recently released documents suggesting that COVID-19 vaccines should be updated yearly.
FDA said that this should be done annually based on the circulating COVID-19 strains in the U.S.
This means that COVID-19 vaccinations would be similar to how people take flu shots year after year.
How to Watch FDA COVID-19 Vaccination Redesign Meeting
According to CNET's latest report, the meeting for FDA's COVID-19 vaccination strategy redesign proposal will happen on Thursday, Jan. 26.
(Photo : Photo by Justin Sullivan/Getty Images)
Jatniel Hernandez fills syringes with COID-19 vaccine booster shots at a COVID-19 vaccination clinic on April 06, 2022 in San Rafael, California. The U.S. Food and Drug Administration has authorized a second COVID-19 booster of Pfizer-BioNTech and Moderna vaccines for people over 50 years old four months after their first booster.
Also Read: Covid-19 Misinformation and Deceptive Claims Are All Over the Internet, Doctors Are Worried
Live streams will be available to the public. For those interested in watching the conference, you can visit the official website of the FDA.
Once you are there, you will see FDA's YouTube link for the meeting. Remember, the conference is scheduled from 8:30 a.m. until 5:30 p.m.
The meeting could end earlier depending on the flow of the discussion.
"The U.S. Food and Drug Administration will hold a meeting of its Vaccines and Related Biological Products Advisory Committee to consider whether and how the composition for primary doses of the currently available COVID-19 vaccines should be modified," said FDA via its official YouTube account.
What FDA Wants
One of the things that FDA wants to change in the COVID-19 vaccination strategy of the U.S. government is the vaccine formulas.
The health department said that they want to limit COVID-19 vaccines to bivalent formulas.
FDA explained that bivalent formulas offer better protection against existing COVID-19 subvariants compared to the original vaccines.
The agency added that simplifying COVID-19 vaccine composition, messaging, and updates could drastically improve vaccine coverage rates in the United States.
As of press time, COVID-19 is still affecting many countries across the globe.
Previously, WHO urged China to provide real-time COVID-19 data amidst surging cases.
We also reported that three winter COVID-19 waves are expected to happen in China.
For more news updates about COVID-19 and other health problems, keep your tabs open here at TechTimes.
Related Article: COVID: New Omicron Subvariant Surge 40.5% in the US this 2023-Cases Rise this New Year
